Pulmicort and Riboflavin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmicort (budesonide) and Riboflavin (riboflavin (vitamin b2)). Common drug interactions include diarrhoea among females and incision site abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmicort and Riboflavin. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Riboflavin?

Riboflavin has active ingredients of riboflavin (vitamin b2). It is often used in migraine. eHealthMe is studying from 2,869 Riboflavin users. Check the latest studies of Riboflavin.



On Jul, 29, 2026

64 people who take Pulmicort and Riboflavin together, and have interactions are studied.

Pulmicort and Riboflavin drug interactions.

What are the common drug interactions of Pulmicort and Riboflavin, by gender? *:

female:

  1. Diarrhoea
  2. Sinusitis (inflammation of sinus)
  3. Dyspnoea (difficult or laboured respiration)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Iron deficiency anaemia
  6. Cough
  7. Fungal infection
  8. Nasal polyps (masses that develop in the lining of the nose)
  9. Chest discomfort
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

male:

  1. Incision site abscess
  2. Infection
  3. Large intestinal obstruction
  4. Lower limb fracture
  5. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  6. Pelvic fracture
  7. Viral infection
  8. Dehydration (dryness resulting from the removal of water)
  9. Device related infection
  10. Bacterial infection

What are the common drug interactions of Pulmicort and Riboflavin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Burning sensation
  2. Erythema (redness of the skin)
  3. Incision site abscess
  4. Infection
  5. Pruritus (severe itching of the skin)
  6. Rash
  7. Dehydration (dryness resulting from the removal of water)
  8. Device related infection
  9. Wisdom teeth removal
  10. Bacterial infection

20-29:

  1. Impaired work ability
  2. Mitochondrial myopathy (the muscle fibres do not function due to damage of mitochondria)

30-39:

  1. Cough
  2. Cystitis (inflammation of the wall of the bladder)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Upper respiratory tract infection

40-49:

  1. Balance disorder
  2. Blindness
  3. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  4. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  5. Dizziness
  6. Fall
  7. Fatigue (feeling of tiredness)
  8. Finger deformity (a deformed position of the finger)
  9. Hot flush (sudden feelings of heat)
  10. Hyperacusis (disorder in loudness perception)

50-59:

  1. Lung disorder (lung disease)

60+:

  1. Sinusitis (inflammation of sinus)
  2. Dyspnoea (difficult or laboured respiration)
  3. Diastolic dysfunction
  4. Disease recurrence
  5. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  8. Embolism venous (embolus may pass into the arterial system)
  9. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  10. Female genital tract fistula (passage in genital tract of female)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 20 people, 31.25%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 21.88%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 20.31%
  4. Inflammatory Bowel Disease: 9 people, 14.06%
  5. Seasonal Allergy (allergic condition due to certain season): 5 people, 7.81%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and Riboflavin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pulmicort and Riboflavin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Riboflavin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Riboflavin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and riboflavin (vitamin b2) (the active ingredients of Pulmicort and Riboflavin, respectively), and Pulmicort and Riboflavin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: